Source comparison
Melanotan-1 Dosage Guide: Research Application Comparison
This comparison table categorizes common Melanotan-1 research applications by dose range, administration frequency, and primary outcome measures. Protocols vary based on target receptor pathways and study duration. Melanogenesis Studies (MC1R) 1.0–2.0mg Daily
This comparison does not assign a generated winner or score.
- This comparison table categorizes common Melanotan-1 research applications by dose range, administration frequency, and primary outcome measures. Protocols vary based on target receptor pathways and study duration.
- Melanogenesis Studies (MC1R)
- 1.0–2.0mg
- Daily during loading, then every 48–72h maintenance
- Skin reflectance spectrometry, eumelanin quantification
- 8–16 weeks
- Gold standard for pigmentation research; requires UV exposure controls and standardized measurement sites
- Appetite Regulation (MC3R/MC4R)
- 0.8–1.5mg
- Daily or every 48h
- Food intake volume, body weight, leptin/ghrelin levels
- 6–12 weeks
- Dose-response plateaus above 1.5mg; nausea incidence limits tolerability at higher ranges
- Cardiovascular Response (MC3R/MC4R CNS)
- 0.5–1.0mg
- Single-dose or daily for 5–7 days
- Blood pressure, heart rate, plasma catecholamines
- Acute (hours) to 2 weeks
- Requires continuous BP monitoring; sympathetic activation evident within 30–60 minutes post-dose
- Receptor Binding Assays (in vitro)
- Variable (nM to μM concentrations)
- Single application
- cAMP accumulation, receptor internalization kinetics
- Hours to 48h
- Dose-response curves require minimum 6-point concentration series; MC1R affinity 0.5–2.0 nM
- Photoprotection Models (EPP/CEP)
- 1.0–1.5mg
- Every 48–72h
- Protoporphyrin levels, phototoxicity scores, sun exposure tolerance
- 12–24 weeks
- Sustained MC1R activation essential; mimics clinical afamelanotide implant protocols